T43.215
Adverse effect of selective serotonin and norepinephrine reuptake inhibitors
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T43.215 refers to adverse effects related to the use of selective serotonin reuptake inhibitors (SSRIs) and norepinephrine reuptake inhibitors (NRIs). These medications are commonly prescribed for depression and anxiety disorders. While effective, they can sometimes cause unwanted side effects, which may require medical attention or adjustment of the medication. Recognizing these adverse effects is important for ensuring proper management and patient safety.
Causes & Symptoms
Clinical Causes: Using SSRIs or NRIs as prescribed, but experiencing adverse reactions due to individual sensitivities Incorrect dosage or prolonged use beyond recommended guidelines Drug interactions with other medications or substances that amplify side effects Underlying medical conditions that increase susceptibility to side effects Genetic factors influencing how the body metabolizes these medications
Key Symptoms: Gastrointestinal issues such as nausea, diarrhea, or constipation Sleep disturbances including insomnia or drowsiness Weight changes—either weight gain or loss Sexual dysfunction, such as decreased libido or difficulty reaching orgasm Headaches or dizziness Increased anxiety or agitation Sweating excessively Tremors or muscle stiffness Serious but rare symptoms may include serotonin syndrome, which can cause hallucinations, rapid heartbeat, or high fever
Diagnostic & Treatment
Diagnosis Path: Diagnosis of adverse effects involves a thorough medical review, including evaluating medication history, symptom description, and physical examination. Healthcare providers may perform blood tests or other assessments to rule out alternative causes or confirm medication-related side effects. It's essential for patients to report all symptoms and medications to their healthcare provider for accurate evaluation.
Treatment Protocols: Addressing adverse effects related to SSRIs and NRIs may include adjusting the medication dosage, switching to another medication, or temporarily discontinuing the drug. Supportive treatments to manage specific symptoms, such as anti-nausea medications or sleep aids, might be recommended. In rare cases of severe reactions like serotonin syndrome, emergency medical intervention is necessary. Always consult a healthcare professional for personalized management strategies.
Clinical Advice & FAQs
Billing Guidance
Is T43.215 a billable ICD-10 code?
Yes, T43.215 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T43.215?
Clinical documentation must specify the nature of Adverse effect of selective serotonin and norepinephrine reuptake inhibitors and any associated comorbidities for accurate reporting.
Cite this Clinical Reference